The 14th International Adenovirus Meeting has been postponed
Dear 14th IAM participants, invited speakers, committee members, sponsors,
in view of the coronavirus pandemic situation, the organizing committee has decided that the best course of action is to postpone the Adenovirus Meeting for one year. The venue has agreed to switch our reservations over to May 18-22, 2021.
- For all abstract presenters and registered participants:
- we will keep your registration, abstract submission and fellowship applications alive for the new meeting
- early on 2021, we will give you the opportunity to update your abstract with your latest results
- For PIs: if one of your lab members is registered but not able to attend the meeting next year, you will be allowed to transfer the registration to another lab member
- For sponsors: the meeting webpage will be alive for the whole year, with your logo displayed on it. You will get extra visibility when we start announcing the meeting again.
- For all adenovirologists: we hope to open a new registration and abstract submission period early in 2021 so new participants can join the postponed meeting.
If you are a registered participant who cannot attend the meeting in 2021 nor transfer your registration to a colleague, you can cancel it by sending an e-mail to the technical secretariat (email@example.com). Since postponement of the 14th IAM will incur costs for venue booking and event management, a cancellation fee of 100€ will be detracted from your refund. Nevertheless, we will reevaluate the possibility of reducing this fee after celebration of the postponed meeting.
We appreciate your understanding in this unusual situation, and look forward to seeing you in Toledo next year.
The 14th IAM organizing committee
Adenoviruses are associated with gastroenteritis, conjunctivitis, respiratory and urinary tract infections which in general have low clinical relevance. However, they can cause severe pathologies, even life-threatening, in immunosuppressed individuals. There is no efficient treatment for adenovirus infections approved so far.
Adenoviruses can also produce serious disease in poultry and other domestic animals, resulting in economic losses. Remarkably, adenoviruses are also the most widely used vectors in the clinical gene therapy field.
Many groups are working to modify the natural properties of adenoviruses and turn them into tools for vaccination, gene transfer, or oncolysis.
The International Adenovirus Meeting is the gathering point for scientists interested in all aspects of adenovirus infection. Worldwide experts share their ideas and latest results on adenovirus detection in nature; their clinical impact; their uses in virotherapies; assembly of the infectious particle; and interaction with the host. The meeting occurred sporadically in the first years since its beginning in 1976, and is now celebrated every two years. The most recent locations were Dobogókö (Hungary, 2009), Umeå (Sweden, 2012), San Diego (California, 2014), Barsinghausen (Germany, 2016), and Cuernavaca (Mexico, 2018).
We invite you to participate in the 14th International Adenovirus Meeting, which will take place in Toledo, Spain, from May 26th to May 30th 2020. This historic city was at a time a melting pot of three cultures, and will welcome us with a great environment and exciting science.
On behalf of the organizing committee,
Carmen San Martín
Group Leader at CNB-CSIC
Coordinator of the Spanish Adenovirus Network (AdenoNet)